Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-18

Clinical Trial Update: Safety and Efficacy of Phenylephrine 2.5%-Tropicamide 1% Microdose Ophthalmic Solution for Pupil Dilation [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of Phenylephrine 2.5%-Tropicamide 1% microdose ophthalmic solution for pupil dilation has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Phenylephrine 2.5%-Tropicamide 1% microdose ophthalmic solution

Snippet

Sponsor: Eyenovia Inc. | Conditions: Mydriasis | Phase 3 | Status: COMPLETED | Results posted: 2022-03-18